Full Access
IMMUNOTHERAPY IN THE TREATMENT OF ACUTE LEUKAEMIA
J. A. Whittaker,
Corresponding Author
J. A. Whittaker
Department of Haematology, Welsh National School of Medicine, Cardiff
Dr J. A. Whittaker, Department of Haematology, Welsh National School of Medicine, University Hospital of Wales, Heath Park, Cardiff CF4 4XW.Search for more papers by this authorJ. A. Whittaker,
Corresponding Author
J. A. Whittaker
Department of Haematology, Welsh National School of Medicine, Cardiff
Dr J. A. Whittaker, Department of Haematology, Welsh National School of Medicine, University Hospital of Wales, Heath Park, Cardiff CF4 4XW.Search for more papers by this author
REFERENCES
- Alexander, P. & Powles, R. (1978) Immunotherapy of human acute leukaemia. Clinks in Haematology, 7, 275–294.
- Andrien, J.M., Beumer-Jockmans, M.P., Bury, J., David, J.L., Delalieux, G., Delbeke, M.J., Denolin, R., De Porre. P., Fiere, D., Flowerdew, G., George, S.L., Hainaut, H., Hughes, J., Denis, Y., Masure, R., Maurus, R., Michel, J., Otten, J., Peetermans, M.E., Reginster-Bous, M., Stryckmans, P.A., Sylvester, R., Van Glabbeke, M., Van Hove, W., Verbist, L., Wennerholm, A. & Williaert, H. (1978) Immunotherapy versus chemotherapy as maintenance treatment of acute lymphoblastic leukemia. Progress in Cancer Research and Therapy. Volume 6. Immunotherapy of Cancer: Present Status of Trials in Man (ed. by W. D. Terry and D. Windhorst), pp. 471–481. Raven Press, New York .
- Bomford, R. (1975) Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells. British Journal of Cancer, 32, 551–557.
- Cuttner, J., Glidewell, O., Holland, J.F. & Bekesi, J.G. (1978) Chemo-immunotherapy of acute myelocytic leukemia with MER. Progress in Cancer Research and Therapy. Volume 6. Immunotherapy of Cancer: Present Status of Trials in Man (ed. by W. D. Terry and D. Windhorst), pp. 405–413. Raven Press, New York .
- Fiere, D., Doillon, M., Martin, C., Vu Van. T. & Revol, L. (1976) Chemoimmunotherapy versus chemotherapy in acute myeloid leukemia: preliminary results. Biomedicine, 25, 319.
-
Galton, D.A.G.,
Kay, H.E.M.,
Reizenstein, P.,
Penchansky, M.,
Vogler, W.R. &
Whittaker, J.A. (1977) Infection and second remission rates in patients having immunotherapy for acute myeloid leukaemia.
Lancet, ii, 973.
10.1016/S0140-6736(77)90905-9 Google Scholar
- Gee, T.S., Dowling, M.D., Cunningham, I., Oettgen, H.S., Armstrong, D. & Clarkson, B.D. (1978) Evaluation of Pseudomonas aeruginosa vaccine for prolongation of remissions in adults with acute nonlymphoblastic leukemia treated with the L-12 protocol: a preliminary report. Progress in Cancer Research and Therapy. Volume 6. Immunotherapy of Cancer: Present Status of Trials in Man (ed. by W. D. Terry and D. Windhorst), pp. 415–422. Raven Press, New York .
-
Goldman, J.M.,
Buskard, N.A. &
Th'ng, K.H. (1976) Bone marrow culture in acute myeloid leukaemia.
Lancet, ii, 260.
10.1016/S0140-6736(76)91065-5 Google Scholar
- Gordon, M.Y., Powles, R.L. & Douglas, I.D.C. (1977) Colony-forming ability of marrow from patients receiving immunotherapy during chemotherapy induced remission in acute myeloid leukaemia. Journal of Clinical Pathology, 30, 70–75.
- Gutterman, J.U., Hersh, E.M., Rodriguez, V., McCredie, K.B., Mavligit, G., Reed, R., Burgess, M.A., Smith, T., Gehan, E., Bodey, G.P. & Freireich, E.J. (1974) Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with BCG. Lancet, ii, 1405–1409.
-
Hamilton Fairley, G. (1975) Immunotherapy in the management of leukaemia.
British Journal of Haematology, 31 (Suppl.), 181–192.
10.1111/j.1365-2141.1975.tb00910.x Google Scholar
- Harris, R., Zuhrie, S.R., Freeman, C.B., Taylor, G.M., MacIver, J.E., Geary, C.G., Delamore, I.W., Hull, P.J. & Tooth, J.A. (1978) Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions. British Journal of Cancer, 37, 282–288.
- Heyn, R.M., Joo, P., Karon, M., Nesbit, M., Shore, N., Breslow, N., Wiener, J., Reed, A. & Hammond, D. (1975) BCG in the treatment of acute lymphocytic leukemia. Blood, 46, 431–442.
- Holland, J.F. & Bekesi, J.G. (1976) Immunotherapy of human leukemia with neuraminidase-modified cells. Medical Clinics of North America, 60, 539–549.
- Leventhal, B.G., Mirro, J. & Konior Yarbro, G.S. (1978) Immune reactivity to tumor antigens in leukemia and lymphoma. Seminars in Hematology, 15, 157–179.
- Mackaness, G.B., Auclair, D.J. & La Grange, P.H. (1973) Immunopotentiation with BCG. 1. Immune response to different strains and preparations. Journal of the National Cancer Institute, 51, 1655–1776.
- Mathé, G., Pouillart, P. & Lapeyraque, F. (1969a) Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells. British Journal of Cancer, 23, 814–824.
- Mathé, G., Amiel, J.L., Schwarzenberg, L., Schneider, M., Cattan, A., Schlumberger, J.R., Hayat, M. & De Vassal, F. (1969b) Active immunotherapy for acute lymphoblastic leukaemia. Lancet, i, 697–699.
-
Mathé, G.,
Schwarzenberg, L.,
De Vassal, F. &
Delgado, M. (1976) Immunotherapy for acute lymphoid leukaemia.
Lancet, i, 143–144.
10.1016/S0140-6736(76)93179-2 Google Scholar
- Milas, L., Gutterman, J.U., Bašic, I., Hunter, N., Mavligit, G.M., Hersh, E.M. & Withers, H.R. (1974) Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum. International Journal of Cancer, 14, 493–503.
- MRC Report (1971) Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (BCG), intermittent methotrexate and no therapy after a five-month intensive cytotoxic regimen (Concord trial). British Medical Journal, iv, 189–194.
- MRC Report (1978) Immunotherapy of acute myeloid leukaemia. British Journal of Cancer, 37, 1–14.
- Murphy, S. & Hersh, E. (1978) Immunotherapy of leukemia and lymphoma. Seminars in Hematology, 15, 181–203.
- Old, L.J. & Boyse, E.A. (1964) Immunology of experimental tumors. Annual Review of Medicine, 15, 167–186.
- Parr, I. (1972) Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. British Journal of Cancer, 26, 174–182.
- Poplack, D.G., Leventhal, B.G., Simon, R., Pomeroy, T., Graw, R.G. & Henderson, E.S. (1978) Treatment of acute lymphatic leukemia with chemotherapy alone or chemotherapy plus immunotherapy. Progress in Cancer Research and Therapy. Volume 6. Immunotherapy of Cancer: Present Status of Trials in Man (ed. by W. D. Terry and D. Windhorst), pp. 497–501. Raven Press, New York .
- Powles, R.L., Balchin, L.A., Hamilton Fairley, G. & Alexander, P. (1971) Recognition of leukaemia cells as foreign before and after autoimmunization. British Medical Journal, i, 486–489.
- Powles, R.L., Crowther, D., Bateman, C.J.T., Beard, M.E.J., McElwain, T.J., Russell, J., Lister, T.A., Whitehouse, J.M.A., Wrigley, P.F.M., Pike, M., Alexander, P. & Hamilton Fairley, G. (1973) Immunotherapy for acute myelogenous leukaemia. British Journal of Cancer, 28, 365–376.
- Powles, R.L., Russell, J., Lister, T.A., Oliver, T., Whitehouse, J.M.A., Malpas, J., Chapuis, B., Crowther, D. & Alexander, P. (1977) Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2·1/2 years after entry of the last patient. British Journal of Cancer, 35, 265–272.
- Reizenstein, P., Brenning, G., Engstedt, L., Franzen, S., Gahrton, G., Gullbring, B., Holm, G., Höckner, P., Höglund, S., Hornsten, P., Jameson, S., Killander, A., Killander, D., Klein, E., Lantz, B., Lindemalm, C., Lockner, D., Lonnqvist, B., Mellstedt, H., Palmblad, J., Pauli, C., Skarberg, K.O., Uden, A-M., Vanky, F. & Wadman, B. (1978) Effect of immunotherapy on survival and remission duration in acute nonlymphatic leukemia. Progress in Cancer Research and Therapy. Volume 6. Immunotherapy of Cancer: Present Status of Trials in Man (ed. by W. D. Terry and D. Windhorst), pp. 329–339. Raven Press, New York .
- Sacks, K.L., Olweny, C., Mann, D.L., Simon, R., Johnson, G.E., Poplack, D.G. & Leventhal, B.G. (1975) A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia. Cancer Research, 35, 3715–3720.
- Sauter, C., Cavalli, F., Lindenmann, J., Gmür, J.P., Berchtold, W., Alberto, P., Obrecht, P. & Senn, H.J. (1978) Viral oncolysis: its application in maintenance treatment of acute myelogenous leukemia. Progress in Cancer Research and Therapy. Volume 6. Immunotherapy of Cancer: Present Status of Trials in Man (ed. by W. D. Terry and D. Windhorst), pp. 355–363. Raven Press, New York .
- Sher, N.A., Chaparas, S.D. & Greenberg, L.E. (1975) The effect of BCG and C. parvum on the mortality from S. aureus septicemia in mice. Proceedings of the American Association for Cancer Research, 16, 18.
- Vogler, W.R. & Chan, Y-K. (1974) Prolonging remission in myeloblastic leukaemia by Tice-strain Bacillus Calmette-Guérin. Lancet, ii, 128–131.
- Weiss, D.W. (1976) MER and other mycobacterial fractions in the immunotherapy of cancer. Medical Clinics of North America, 60, 473–497.
- Weiss, D.W., Stupp, Y., Many, M. & Izak, G. (1975) Treatment of acute myclocytic leukemia patients with the MER tubercle bacillus fraction. A preliminary report. Transplantation Proceedings, 7, 545–552.
-
Whiteside, M.G.,
Cauchi, M.N.,
Paton, C. &
Stone, J. (1976) Chemoimmunotherapy for maintenance in acute myeloblastic leukemia.
Cancer, 38, 1581–1586.
10.1002/1097-0142(197610)38:4<1581::AID-CNCR2820380423>3.0.CO;2-Y CAS PubMed Web of Science® Google Scholar
- Whittaker, J.A., Bailey-Wood, R. & Hutchins, S. (1980) Active immunotherapy for the treatment of acute myelogenous leukaemia: report of two controlled trials. British Journal of Haematology (in press).
- Whittaker, J.A. & Slater, A.J. (1977) The immunotherapy of acute myelogenous leukaemia using intravenous BCG. British Journal of Haematology, 35, 263–273.
- Zinkernagel, R.M. & Doherty, P.C. (1975) H-2 compatibility requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis. Journal of Experimental Medicine, 141, 1427–1436.
Citing Literature
